Nanobiotix (NBTX) Liabilities and Shareholders Equity: 2020-2025

  • Nanobiotix's Liabilities and Shareholders Equity fell 45.22% to $51.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $317.5 million, marking a year-over-year decrease of 2.11%. This contributed to the annual value of $72.0 million for FY2024, which is 29.07% down from last year.
  • According to the latest figures from Q2 2025, Nanobiotix's Liabilities and Shareholders Equity is $51.1 million, which was down 29.02% from $72.0 million recorded in Q4 2024.
  • In the past 5 years, Nanobiotix's Liabilities and Shareholders Equity registered a high of $149.2 million during Q2 2021, and its lowest value of $44.0 million during Q2 2023.
  • For the 3-year period, Nanobiotix's Liabilities and Shareholders Equity averaged around $72.3 million, with its median value being $72.0 million (2024).
  • As far as peak fluctuations go, Nanobiotix's Liabilities and Shareholders Equity crashed by 48.86% in 2023, and later soared by 112.15% in 2024.
  • Nanobiotix's Liabilities and Shareholders Equity (Quarterly) stood at $116.4 million in 2021, then tumbled by 42.35% to $86.0 million in 2022, then slumped by 48.86% to $101.0 million in 2023, then dropped by 28.69% to $72.0 million in 2024, then tumbled by 45.22% to $51.1 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $51.1 million for Q2 2025, versus $72.0 million for Q4 2024 and $93.3 million for Q2 2024.